The Impact of an Educational Discharge Video on Post-Operative Health Care Utilization After Holmium Laser Enucleation of the Prostate (HoLEP) Procedures

NCT ID: NCT06975033

Last Updated: 2025-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

114 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This will be a randomized interventional study. Patients scheduled to undergo a HoLEP at UCSF will be randomized into two groups after the procedure: one group will watch a scripted educational HoLEP video and the other group will not receive a video. We will monitor the post-operative care utilization after discharge. Secondary outcomes will include patient satisfaction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HoLEP Patient Satisfaction Educational Video Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video

Participants will watch video.

Group Type EXPERIMENTAL

Video

Intervention Type OTHER

Participants will watch video.

No Video

Participants will not watch video.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video

Participants will watch video.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults aged 18+
2. Patients scheduled for a HoLEP procedure
3. Patients willing to complete both baseline and follow up surveys
4. Patients able to provide informed consent
5. Patients are English-speaking and understand English

Exclusion Criteria

1. Patients under 18+
2. Patients unable to consent
3. Patients unable to complete surveys
4. Patients without a prostate.
5. Patients are non-English speakers
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

State University of New York - Upstate Medical University

OTHER

Sponsor Role collaborator

University of Rochester

OTHER

Sponsor Role collaborator

University of California, San Francisco

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Bayne, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, San Francisco

San Francisco, California, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Scott SUNY Upstate Medical University

Syracuse, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Bayne, MD, MPH

Role: CONTACT

617-571-5870

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Bayne Bayne

Role: primary

617-571-5870

Scott Quarrier Quarier

Role: primary

Rajat Jain

Role: backup

Scott Wiener Wiener

Role: primary

774-239-2512

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

25-43311

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HoLEP Vs BPEP for Large Prostatic Adenoma
NCT04275076 COMPLETED PHASE3